Bacterial Resistance and Impetigo Treatment Trends: A Review

  1. Scott Bangert M.D.1,
  2. Moise Levy M.D.2,3,
  3. Adelaide A. Hebert M.D.1

Article first published online: 3 FEB 2012

DOI: 10.1111/j.1525-1470.2011.01700.x

Issue

Pediatric Dermatology

Pediatric Dermatology

Volume 29, Issue 3, pages 243–248, May/June 2012

Additional Information

How to Cite

Bangert, S., Levy, M. and Hebert, A. A. (2012), Bacterial Resistance and Impetigo Treatment Trends: A Review. Pediatric Dermatology, 29: 243–248. doi: 10.1111/j.1525-1470.2011.01700.x

Author Information

  1. 1

    Dermatology, The University of Texas Health Science Center at Houston

  2. 2

    Dell Children’s Medical Center, Pediatric Dermatology, University of Texas Southwestern, Dermatology

  3. 3

    Baylor College of Medicine, Pediatrics and Dermatology

*Address correspondence to Scott Bangert, M.D., UT Houston Department of Dermatology, 6655 Travis, Suite 980, Houston, TX 77030, or e-mail: scobang@aol.com.

Publication History

  1. Issue published online: 17 MAY 2012
  2. Article first published online: 3 FEB 2012

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (98K)

Abstract:  Impetigo is a common cutaneous infection that is especially prevalent in children. The prevalence of colonization and infection with resistant strains is continually increasing, forcing clinicians to reevaluate treatment strategies. Newer topical agents are effective in treating infections with resistant strains and may help minimize resistance and adverse effects from systemic agents. Use of topical disinfectants to decrease colonization is an important adjunctive measure. Physicians should be aware of local resistance patterns in impetigo to help guide therapy.

View Full Article (HTML) Get PDF (98K)